Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Celltech to regain rights to CDP-870 from Pfizer

Dec. 3, 2003

Fast track designation for TheraCLEC

Dec. 3, 2003

Liver histology improvements in phase III study of emtricitabine for hepatitis B

Nov. 28, 2003

Phase III program commences for PTI-901 in IBS

Nov. 27, 2003

Zeria presents novel gastric antisecretory agents in a recent patent

Nov. 25, 2003

Phase I study of oral methylnaltrexone commences dosing

Nov. 25, 2003

BioBalance commences enrollment in IBS trial of Probactrix

Nov. 21, 2003

New HCV NS3-NS4A protease inhibitors under study at Vertex

Nov. 21, 2003

Proton pump inhibitors and cytochrome P-450 polymorphism in GERD

Nov. 18, 2003

Therapeutic benefits of rabeprazole in ulcers and GERD

Nov. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...